Benzinga | Apr 29, 2021 10:00AM EDT

Citigroup Maintains Buy on Hologic, Lowers Price Target to $80

Citigroup analyst Patrick Donnelly maintains Hologic (NASDAQ:HOLX) with a Buy and lowers the price target from $90 to $80.